Literature DB >> 15387372

Differences between scirrhous and non-scirrhous human gastric carcinomas from the aspect of proMMP-2 activation regulated by TIMP-3.

Takeyoshi Yokoyama1, Hiroyuki Nakamura, Yoshihide Otani, Tetsuro Kubota, Noboru Fujimoto, Motoharu Seiki, Masaki Kitajima, Yasunori Okada.   

Abstract

Gastric carcinomas can be classified into scirrhous carcinomas (SC), i.e. 'linitis plastica' or Borrmann 4 gastric cancer, and non-scirrhous carcinomas (NSC). SC are characterized by diffuse invasive growth patterns with marked fibrosis, frequent peritoneal dissemination and lymph-node metastases and poor prognosis, while NSC show medullary growth patterns and common hematogenous metastases. To study the differences in local expression levels of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) between SC and NSC, we examined the expression of MMPs and TIMPs in human gastric carcinoma tissues by several methods including sandwich-enzyme immunoassay systems, gelatin zymography, reverse transcriptase-polymerase chain reaction (RT-PCR), real-time quantitative PCR, immunoblotting, immunohistochemistry and in situ zymography. Of the seven MMPs and two TIMPs tested, only proMMP-2 levels were remarkably higher in SC than in NSC (P < 0.01), and proMMP-2 activation ratio was significantly lower in SC than in NSC (P < 0.05). TIMP-3 mRNA levels were remarkably about 2-fold higher in SC than in NSC tissues (P < 0.01). TIMP-3 production in SC was confirmed by immunoblotting and TIMP-3 was immunolocalized to stromal fibroblasts in SC. TIMP-3 mRNA levels inversely correlated with proMMP-2 activation ratios, although the expression levels of MT1-MMP and MT2-MMP were not different in SC and NSC. By in situ zymography, gelatinolytic activity appeared to be weaker in SC than in NSC. All these data suggest that proMMP-2 activation is down-regulated by TIMP-3 expressed in scirrhous gastric carcinomas. Our findings may explain the differences in clinical behaviors of SC and NSC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15387372     DOI: 10.1023/b:clin.0000037704.72028.72

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  43 in total

1.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors:  P LAUREN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

2.  Real time quantitative PCR.

Authors:  C A Heid; J Stevens; K J Livak; P M Williams
Journal:  Genome Res       Date:  1996-10       Impact factor: 9.043

3.  Marked increase of trypsin(ogen) in serum of linitis plastica (gastric cancer, borrmann 4) patients.

Authors:  Y Ichikawa; N Koshikawa; S Hasegawa; T Ishikawa; N Momiyama; C Kunizaki; M Takahashi; Y Moriwaki; H Akiyama; H Yamaoka; S Yanoma; A Tsuburaya; Y Nagashima; H Shimada; K Miyazaki
Journal:  Clin Cancer Res       Date:  2000-04       Impact factor: 12.531

4.  Transcriptional inactivation of the tissue inhibitor of metalloproteinase-3 gene by dna hypermethylation of the 5'-CpG island in human gastric cancer cell lines.

Authors:  S H Kang; H H Choi; S G Kim; H S Jong; N K Kim; S J Kim; Y J Bang
Journal:  Int J Cancer       Date:  2000-06-01       Impact factor: 7.396

5.  Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.

Authors:  H Ueno; H Nakamura; M Inoue; K Imai; M Noguchi; H Sato; M Seiki; Y Okada
Journal:  Cancer Res       Date:  1997-05-15       Impact factor: 12.701

6.  Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers.

Authors:  K E Bachman; J G Herman; P G Corn; A Merlo; J F Costello; W K Cavenee; S B Baylin; J R Graff
Journal:  Cancer Res       Date:  1999-02-15       Impact factor: 12.701

7.  Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.

Authors:  M Nakada; H Nakamura; E Ikeda; N Fujimoto; J Yamashita; H Sato; M Seiki; Y Okada
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

8.  Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.

Authors:  H Nakamura; H Ueno; K Yamashita; T Shimada; E Yamamoto; M Noguchi; N Fujimoto; H Sato; M Seiki; Y Okada
Journal:  Cancer Res       Date:  1999-01-15       Impact factor: 12.701

9.  Clinicopathological analysis of the intestinal type and diffuse type of gastric carcinoma.

Authors:  S Noda; K Soejima; K Inokuchi
Journal:  Jpn J Surg       Date:  1980-12

10.  Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma.

Authors:  C F Sier; F J Kubben; S Ganesh; M M Heerding; G Griffioen; R Hanemaaijer; J H van Krieken; C B Lamers; H W Verspaget
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

View more
  4 in total

1.  Detection of TIMP3 promoter hypermethylation in salivary rinse as an independent predictor of local recurrence-free survival in head and neck cancer.

Authors:  Wenyue Sun; David Zaboli; Hao Wang; Yan Liu; Demetri Arnaoutakis; Tanbir Khan; Zubair Khan; Wayne M Koch; Joseph A Califano
Journal:  Clin Cancer Res       Date:  2012-01-06       Impact factor: 12.531

2.  Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer.

Authors:  F J G M Kubben; C F M Sier; W van Duijn; G Griffioen; R Hanemaaijer; C J H van de Velde; J H J M van Krieken; C B H W Lamers; H W Verspaget
Journal:  Br J Cancer       Date:  2006-04-10       Impact factor: 7.640

3.  Hyaluronan inhibits expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic chondrocytes.

Authors:  T Yatabe; S Mochizuki; M Takizawa; M Chijiiwa; A Okada; T Kimura; Y Fujita; H Matsumoto; Y Toyama; Y Okada
Journal:  Ann Rheum Dis       Date:  2008-07-28       Impact factor: 19.103

4.  Expression of the matrix metalloproteases 2, 14, 24, and 25 and tissue inhibitor 3 as potential molecular markers in advanced human gastric cancer.

Authors:  Sol de la Peña; Clara Luz Sampieri; Mariana Ochoa-Lara; Kenneth León-Córdoba; José María Remes-Troche
Journal:  Dis Markers       Date:  2014-02-11       Impact factor: 3.434

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.